CompletedPhase 4NCT01811355
Mexiletine for the Treatment of Muscle Cramps in ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bjorn Oskarsson, MD
- Principal Investigator
- Bjorn Oskarsson, MDUC Davis
- Intervention
- Mexiletine(drug)
- Enrollment
- 23 enrolled
- Eligibility
- 21-89 years · All sexes
- Timeline
- 2013 – 2016
Study locations (6)
- UCD Telehealth Network - Lake Almanor Clinic, Chester, California, United States
- UCSD Department of Neurosciences ALS Clinical Trials (ACT) Program, La Jolla, California, United States
- UCLA Neuromuscular Research Program, Los Angeles, California, United States
- UCD Telehealth Network, Multiple Locations, California, United States
- UC Irvine Health ALS & Neuromuscular Center, Orange, California, United States
- UC, Davis Medical Center ALS Clinic, Sacramento, California, United States
Collaborators
University of California, Davis · ALS Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01811355 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)